Medicis Announces Approval of Additional Strengths of Solodyn(R) bi2641071 SCOTTSDALE, Ariz. -- Medicis today announced that the U.S. Food and Drug Administration has approved additional strengths of SOLODYN Extended Release Tablets 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris patients 12 years of age and older

Medicis to Present at Bank of America Merrill Lynch Conference bi2641071 SCOTTSDALE, Ariz. -- Medicis today announced that the Company scheduled to present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Southampton, New York

Obagi Medical Products? Second Quarter 2010 Net Sales Rose 12 Percent bi2641071 LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader topical aesthetic and therapeutic skin health systems, today reported financial results for the second quarter and six months ended June 30, 2010. Net sales the second quarter of 2010 rose 11.6% to $28.9 million from $25.9 million the second quarter a year ago, demonstrating continued strength ..

Medicis Reports Second Quarter 2010 Financial Results bi2641071 SCOTTSDALE, Ariz. -- Medicis today announced revenues of approximately $174.0 million for the three months ended June 30, 2010, compared to revenues of approximately $141.2 million for the three months ended June 30, 2009, represents an increase of approximately $32.8 million, or approximately 23.2%

New Acne Treatment Product, Coral Actives, Launched by Ermis Labs bi2641071 ermis LABS thrilled to announce the release of new acne skin care line, Coral Actives. These new acne treatment products differentiate from the rest by combining the best of proven medicines the benefits of sea whip extract, provides a very potent, natural anti-inflammatory extract that safe, effective and environmentally friendly

Medicis Announces Approval of Additional Strengths of Solodyn(R) bi2641071 SCOTTSDALE, Ariz. -- Medicis today announced that the U.S. Food and Drug Administration has approved additional strengths of SOLODYN Extended Release Tablets 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris patients 12 years of age and older

I have acne. What am I doing wrong? bi2641071 Many of my patients acne say they feel as though they must be doing something wrong to be cursed disfiguring disease. Many suffer from guilt, ranging from lack of personal hygiene to having "bad thoughts" and thinking acne punishment

Unigen Announces the Launch of Bakutrol? - Powerful Triple-Acting Skin Care I bi2641071 Unigen, Inc. announces the launch of Bakutrol?, a powerful triple-acting botanical skin care ingredient offering anti-microbial, anti-inflammatory and anti-scarring benefits

Proactiv solved Katy Perry's acne problem bi2641071 HERE'S something you might not know about the effervescent singer Katy Perry: She once suffered from bad acne. "I started getting acne really bad when I started touring," said Perry, 25, who was here to play at Singfest recently

Simple steps to a flawless face bi2641071 Not everyone has picture-perfect pores. If your skin tends to be on the oily side, improper care can lead to acne, on top of unwanted shine

Upgrade Your Acne Treatment With A Push of A Button bi2641071 Advanced design and unparalleled benefits, Teen Tända Clear?Acne Light Therapy Treatment the way of the future

Medicis to Present at Bank of America Merrill Lynch Conference bi2641071 SCOTTSDALE, Ariz. -- Medicis today announced that the Company scheduled to present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Southampton, New York

Justin Bieber Is Proactiv® bi2641071 Singing sensation Justin Bieber speaking out as a huge fan - and has just been named a spokesperson - of ProactivÂ®, America's #1 acne system. Â Bieber talk to teens about being proactive about acne and skin care to prevent breakouts as part of the brand's unique Be ProactivÂ® marketing campaign

Kid Party Favors - Home